866-997-4948(US-Canada Toll Free)

United States Neuroleptic Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 95 Pages

In this report, the United States Neuroleptic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.



Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Neuroleptic in these regions, from 2012 to 2022 (forecast).



United States Neuroleptic market competition by top manufacturers/players, with Neuroleptic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Johnson & Johnso

Pfizer

Eli Lilly

Bristol-Myers Squibb

GlaxoSmithKline

...



On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Droperidol

Midazolam

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Neuroleptic for each application, including

Medical Care

Scientific Research

Others



If you have any special requirements, please let us know and we will offer you the report as you want.



Table of Contents

United States Neuroleptic Market Report 2017
1 Neuroleptic Overview
1.1 Product Overview and Scope of Neuroleptic
1.2 Classification of Neuroleptic by Product Category
1.2.1 United States Neuroleptic Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Neuroleptic Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Droperidol
1.2.4 Midazolam
1.3 United States Neuroleptic Market by Application/End Users
1.3.1 United States Neuroleptic Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 United States Neuroleptic Market by Region
1.4.1 United States Neuroleptic Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Neuroleptic Status and Prospect (2012-2022)
1.4.3 Southwest Neuroleptic Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Neuroleptic Status and Prospect (2012-2022)
1.4.5 New England Neuroleptic Status and Prospect (2012-2022)
1.4.6 The South Neuroleptic Status and Prospect (2012-2022)
1.4.7 The Midwest Neuroleptic Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Neuroleptic (2012-2022)
1.5.1 United States Neuroleptic Sales and Growth Rate (2012-2022)
1.5.2 United States Neuroleptic Revenue and Growth Rate (2012-2022)

2 United States Neuroleptic Market Competition by Players/Suppliers
2.1 United States Neuroleptic Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Neuroleptic Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Neuroleptic Average Price by Players/Suppliers (2012-2017)
2.4 United States Neuroleptic Market Competitive Situation and Trends
2.4.1 United States Neuroleptic Market Concentration Rate
2.4.2 United States Neuroleptic Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Neuroleptic Manufacturing Base Distribution, Sales Area, Product Type

3 United States Neuroleptic Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Neuroleptic Sales and Market Share by Region (2012-2017)
3.2 United States Neuroleptic Revenue and Market Share by Region (2012-2017)
3.3 United States Neuroleptic Price by Region (2012-2017)

4 United States Neuroleptic Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Neuroleptic Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Neuroleptic Revenue and Market Share by Type (2012-2017)
4.3 United States Neuroleptic Price by Type (2012-2017)
4.4 United States Neuroleptic Sales Growth Rate by Type (2012-2017)

5 United States Neuroleptic Sales (Volume) by Application (2012-2017)
5.1 United States Neuroleptic Sales and Market Share by Application (2012-2017)
5.2 United States Neuroleptic Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Neuroleptic Players/Suppliers Profiles and Sales Data
6.1 Johnson & Johnso
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Neuroleptic Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Johnson & Johnso Neuroleptic Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.2 Neuroleptic Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer Neuroleptic Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly
6.3.2 Neuroleptic Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly Neuroleptic Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Bristol-Myers Squibb
6.4.2 Neuroleptic Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bristol-Myers Squibb Neuroleptic Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
6.5.2 Neuroleptic Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GlaxoSmithKline Neuroleptic Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...

7 Neuroleptic Manufacturing Cost Analysis
7.1 Neuroleptic Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neuroleptic

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Neuroleptic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neuroleptic Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Neuroleptic Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Neuroleptic Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Neuroleptic Sales Volume Forecast by Type (2017-2022)
11.3 United States Neuroleptic Sales Volume Forecast by Application (2017-2022)
11.4 United States Neuroleptic Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Neuroleptic
Figure United States Neuroleptic Market Size (K Pcs) by Type (2012-2022)
Figure United States Neuroleptic Sales Volume Market Share by Type (Product Category) in 2016
Figure Droperidol Product Picture
Figure Midazolam Product Picture
Figure United States Neuroleptic Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Neuroleptic by Application in 2016
Figure Medical Care Examples
Table Key Downstream Customer in Medical Care
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Neuroleptic Market Size (Million USD) by Region (2012-2022)
Figure The West Neuroleptic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Neuroleptic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Neuroleptic Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Neuroleptic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Neuroleptic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Neuroleptic Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neuroleptic Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Neuroleptic Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neuroleptic Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Neuroleptic Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Neuroleptic Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neuroleptic Sales Share by Players/Suppliers
Figure 2017 United States Neuroleptic Sales Share by Players/Suppliers
Figure United States Neuroleptic Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Neuroleptic Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Neuroleptic Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neuroleptic Revenue Share by Players/Suppliers
Figure 2017 United States Neuroleptic Revenue Share by Players/Suppliers
Table United States Market Neuroleptic Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Neuroleptic Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Neuroleptic Market Share of Top 3 Players/Suppliers
Figure United States Neuroleptic Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Neuroleptic Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Neuroleptic Product Category
Table United States Neuroleptic Sales (K Pcs) by Region (2012-2017)
Table United States Neuroleptic Sales Share by Region (2012-2017)
Figure United States Neuroleptic Sales Share by Region (2012-2017)
Figure United States Neuroleptic Sales Market Share by Region in 2016
Table United States Neuroleptic Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Neuroleptic Revenue Share by Region (2012-2017)
Figure United States Neuroleptic Revenue Market Share by Region (2012-2017)
Figure United States Neuroleptic Revenue Market Share by Region in 2016
Table United States Neuroleptic Price (USD/Pcs) by Region (2012-2017)
Table United States Neuroleptic Sales (K Pcs) by Type (2012-2017)
Table United States Neuroleptic Sales Share by Type (2012-2017)
Figure United States Neuroleptic Sales Share by Type (2012-2017)
Figure United States Neuroleptic Sales Market Share by Type in 2016
Table United States Neuroleptic Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Neuroleptic Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neuroleptic by Type (2012-2017)
Figure Revenue Market Share of Neuroleptic by Type in 2016
Table United States Neuroleptic Price (USD/Pcs) by Types (2012-2017)
Figure United States Neuroleptic Sales Growth Rate by Type (2012-2017)
Table United States Neuroleptic Sales (K Pcs) by Application (2012-2017)
Table United States Neuroleptic Sales Market Share by Application (2012-2017)
Figure United States Neuroleptic Sales Market Share by Application (2012-2017)
Figure United States Neuroleptic Sales Market Share by Application in 2016
Table United States Neuroleptic Sales Growth Rate by Application (2012-2017)
Figure United States Neuroleptic Sales Growth Rate by Application (2012-2017)
Table Johnson & Johnso Basic Information List
Table Johnson & Johnso Neuroleptic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnso Neuroleptic Sales Growth Rate (2012-2017)
Figure Johnson & Johnso Neuroleptic Sales Market Share in United States (2012-2017)
Figure Johnson & Johnso Neuroleptic Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Neuroleptic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Neuroleptic Sales Growth Rate (2012-2017)
Figure Pfizer Neuroleptic Sales Market Share in United States (2012-2017)
Figure Pfizer Neuroleptic Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Neuroleptic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Neuroleptic Sales Growth Rate (2012-2017)
Figure Eli Lilly Neuroleptic Sales Market Share in United States (2012-2017)
Figure Eli Lilly Neuroleptic Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Neuroleptic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Neuroleptic Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Neuroleptic Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Neuroleptic Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Neuroleptic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Neuroleptic Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Neuroleptic Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Neuroleptic Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuroleptic
Figure Manufacturing Process Analysis of Neuroleptic
Figure Neuroleptic Industrial Chain Analysis
Table Raw Materials Sources of Neuroleptic Major Players/Suppliers in 2016
Table Major Buyers of Neuroleptic
Table Distributors/Traders List
Figure United States Neuroleptic Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Neuroleptic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Neuroleptic Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Neuroleptic Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Neuroleptic Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Neuroleptic Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Neuroleptic Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Neuroleptic Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Neuroleptic Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Neuroleptic Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Neuroleptic Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neuroleptic Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neuroleptic Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *